The Column Group (TCG) is a science-driven venture capital firm that makes significant financial and operational commitments to build early-stage drug discovery companies based on their unique scientific platforms and potential to deliver multiple breakthrough therapeutics.

Venture Capital

The Column Group

Managing Partners

Peter Svennilson

Tim Kutzkey

David V. Goeddel

Brian Wong

Hui Tian

Annalisa Altamura

Shannon Stone

Micha Rapé

Leon Chen

Larry Lasky

John Josey

Sarah Hymowitz

Jeff Goater

Vishva Dixit

Charles Zuker

Eric Olson

Charles Sawyers

Helen Hobbs

Richard Scheller

Robert Tjian

Huda Zoghbi

Roger Perlmutter

Millie Ray

Jennifer A. Doudna

Michael Fischbach

K. Chris Garcia

Susan Murakami

Carla Daniel

James Evangelista

The Column Group's leadership team has a wealth of experience in the biotech industry. The Senior VP used to work at Amgen, the CEO used to work at Tularik, and the Director of Molecular Biology used to work at Genentech. The team also has experience working in academia, with the President and Chief Scientific Officer having previously worked as a lecturer at UC Berkeley.

Leadership Team

Science Partners

Partners

��

Leadership Team

About

Team members

Other teams at The Column Group

Science Partners

Partners

��������

Leadership Team

About

Team members

Other teams at The Column Group

Science Partners

Partners

��